Literature DB >> 27725112

Gene expression profiling of the astrocyte transcriptome in multiple sclerosis normal appearing white matter reveals a neuroprotective role.

Rachel Waller1, M Nicola Woodroofe2, Stephen B Wharton1, Paul G Ince1, Simona Francese2, Paul R Heath1, Alex Cudzich-Madry2, Ruth H Thomas2, Natalie Rounding1, Basil Sharrack3, Julie E Simpson4.   

Abstract

Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the central nervous system (CNS). White matter lesions in MS are surrounded by areas of non-demyelinated normal appearing white matter (NAWM) with complex pathology, including blood brain barrier dysfunction, axonal damage and glial activation. Astrocytes, the most abundant cell type within the CNS, may respond and/or contribute to lesion pathogenesis. We aimed to characterise the transcriptomic profile of astrocytes in NAWM to determine whether specific glial changes exist in the NAWM which contribute to lesion development or prevent disease progression. Astrocytes were isolated from control and NAWM by laser capture microdissection (LCM), using glial fibrillary acidic protein (GFAP) as a marker, and the astrocyte transcriptome determined using microarray analysis. 452 genes were significantly differentially expressed (208 up-regulated and 244 down-regulated, FC≥1.5 and p-value≤0.05). Within the NAWM, astrocytes were associated with significant upregulation of genes involved in the control of iron homeostasis (including metallothionein-1 and -2, ferritin light chain and transferrin), oxidative stress responses, the immune response and neurotrophic support. These findings suggest a neuroprotective role of astrocytes in the NAWM in MS.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Astrocyte; Microarray; Multiple sclerosis; Neuroprotection; Normal appearing white matter

Mesh:

Year:  2016        PMID: 27725112     DOI: 10.1016/j.jneuroim.2016.09.010

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  17 in total

Review 1.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 2.  TGF-β as a Key Modulator of Astrocyte Reactivity: Disease Relevance and Therapeutic Implications.

Authors:  Jian Luo
Journal:  Biomedicines       Date:  2022-05-23

Review 3.  Cotinine: A Therapy for Memory Extinction in Post-traumatic Stress Disorder.

Authors:  Cristhian Mendoza; George E Barreto; Alexandre Iarkov; Vadim V Tarasov; Gjumrakch Aliev; Valentina Echeverria
Journal:  Mol Neurobiol       Date:  2018-01-15       Impact factor: 5.590

4.  High fat diet consumption results in mitochondrial dysfunction, oxidative stress, and oligodendrocyte loss in the central nervous system.

Authors:  Monica R Langley; Hyesook Yoon; Ha Neui Kim; Chan-Il Choi; Whitney Simon; Laurel Kleppe; Ian R Lanza; Nathan K LeBrasseur; Aleksey Matveyenko; Isobel A Scarisbrick
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-12-06       Impact factor: 6.633

5.  Cortical Surface Area Rather Than Cortical Thickness Potentially Differentiates Radiation Encephalopathy at Early Stage in Patients With Nasopharyngeal Carcinoma.

Authors:  You-Ming Zhang; Ming-Na Chen; Xiao-Ping Yi; Li Li; Jian-Ming Gao; Jin-Lei Zhang; Xin-Ru Yuan; Na Zhang; Li-Zhi Liu; Pei-Qiang Cai; Bihong T Chen; Chishing Zee; Wei-Hua Liao; Yuan-Chao Zhang
Journal:  Front Neurosci       Date:  2018-08-27       Impact factor: 4.677

Review 6.  Molecular mechanisms of neurodegeneration in the entorhinal cortex that underlie its selective vulnerability during the pathogenesis of Alzheimer's disease.

Authors:  Olayemi Joseph Olajide; Marcus E Suvanto; Clifton Andrew Chapman
Journal:  Biol Open       Date:  2021-01-25       Impact factor: 2.422

Review 7.  Astrocyte phenotypes: Emphasis on potential markers in neuroinflammation.

Authors:  Iva Bozic; Danijela Savic; Irena Lavrnja
Journal:  Histol Histopathol       Date:  2020-11-23       Impact factor: 2.303

8.  SPK1-transfected UCMSC has better therapeutic activity than UCMSC in the treatment of experimental autoimmune encephalomyelitis model of Multiple sclerosis.

Authors:  Yun-Liang Wang; Peng Xue; Chun-Yang Xu; Zhen Wang; Xin-Shan Liu; Lin-Lin Hua; Hong-Ying Bai; Zhi-Lei Zeng; Hai-Feng Duan; Jin-Feng Li
Journal:  Sci Rep       Date:  2018-01-29       Impact factor: 4.379

9.  Sensorimotor and pain-related alterations of the gray matter and white matter in Type 2 diabetic patients with peripheral neuropathy.

Authors:  Youming Zhang; Minli Qu; Xiaoping Yi; Pei Zhuo; Jingyi Tang; Xin Chen; Gaofeng Zhou; Ping Hu; Ting Qiu; Wu Xing; Yitao Mao; Bihong T Chen; Jing Wu; Yuanchao Zhang; Weihua Liao
Journal:  Hum Brain Mapp       Date:  2019-10-29       Impact factor: 5.038

Review 10.  High-Resolution Transcriptomic and Proteomic Profiling of Heterogeneity of Brain-Derived Microglia in Multiple Sclerosis.

Authors:  Anneke Miedema; Marion H C Wijering; Bart J L Eggen; Susanne M Kooistra
Journal:  Front Mol Neurosci       Date:  2020-10-22       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.